News
Opioid addicts covered by Medicare and Medicaid are less likely to receive the mental health and substance use treatment that ...
Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...
An mRNA-based seasonal flu vaccine from Moderna was 27 percent more effective at preventing influenza infections than a ...
This summary encapsulates recent health updates including Carmat's insolvency filing, Bayer's glyphosate litigation in the U.S. Supreme Court, FDA's label revisions for ADHD stimulants, a U.S. House ...
The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...
Stanley Black & Decker has designated Christopher Nelson to succeed Donald Allan Jr. as president and chief executive of the tool maker, effective Oct. 1. Financial services companies like BNY and ...
Moderna shares rose on the increased effectiveness of its flu vaccine in late-stage trials, bring the biotech company closer ...
Moderna’s experimental mRNA-based flu vaccine demonstrated a stronger immune response than a currently available standard flu shot in a late-stage phase 3 trial, clearing a path for regulatory ...
The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.
Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the ...
The mRNA drug developer said it will begin discussing approval with the FDA, which has adopted stricter vaccine review standards.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results